Ibuprofen for Acute Pericarditis
Yes, ibuprofen is a first-line, Class I Level A recommended treatment for acute pericarditis in healthy adults, dosed at 600 mg every 8 hours for 1-2 weeks with gradual tapering, and must be combined with colchicine for 3 months. 1
Dosing Protocol
Initial Treatment:
- Ibuprofen: 600 mg every 8 hours (total 1800 mg/day) 1
- Duration: 1-2 weeks for uncomplicated cases, guided by symptom resolution and C-reactive protein (CRP) normalization 1
- Mandatory gastroprotection (proton pump inhibitor or H2 blocker) 1
Tapering Schedule:
- Decrease by 200-400 mg every 1-2 weeks 1
- Only taper when patient is asymptomatic AND CRP is normalized 1
- Treatment duration is symptoms and CRP-guided, not calendar-based 1
Critical Combination Therapy
Colchicine is mandatory as adjunctive therapy (Class I Level A recommendation):
- Dose: 0.5 mg twice daily if ≥70 kg; 0.5 mg once daily if <70 kg 1
- Duration: 3 months minimum 1
- This combination reduces recurrence rates from 37.5% to 16.7% (absolute risk reduction 20.8%) 2
- Colchicine tapering is not mandatory but can be considered in final weeks 1
Evidence Strength
The 2015 ESC Guidelines provide the highest quality evidence, designating aspirin or NSAIDs (including ibuprofen) as Class I Level A recommendations for first-line therapy 1. This is reinforced by recent 2024 safety data showing ibuprofen use for acute pericarditis was associated with a 25% reduction in major adverse cardiovascular events (adjusted HR 0.75,95% CI: 0.67-0.85) compared to non-use, dispelling concerns about cardiovascular risks at these doses 3.
When to Choose Ibuprofen Over Aspirin
Ibuprofen is preferred when:
- Patient does NOT have coronary artery disease, heart failure, or significant renal disease 4
- Patient is not already on aspirin for antiplatelet therapy 1
- Cost and accessibility are considerations (ibuprofen is inexpensive and widely available) 4
Choose aspirin instead when:
- Patient has coronary artery disease requiring antiplatelet therapy 1, 4
- Patient has heart failure or renal disease 4
- Dose: Aspirin 750-1000 mg every 8 hours 1
Common Pitfalls to Avoid
Do NOT use corticosteroids as first-line therapy (Class III recommendation):
- Corticosteroids favor chronic disease evolution and drug dependence 1
- They increase recurrence rates up to 50% 1
- Reserve for contraindications/failure of NSAIDs and colchicine, or specific indications (autoimmune disease, pregnancy) 1
Do NOT taper too rapidly:
- Rapid tapering (within 1 month) increases recurrence risk 5
- Each dose reduction should occur only when asymptomatic with normal CRP 1
Do NOT skip colchicine:
Monitoring Requirements
- CRP levels should guide treatment duration and tapering decisions 1
- Continue full-dose therapy until symptoms resolve AND CRP normalizes 1
- Exercise restriction until symptom resolution and normalization of CRP, ECG, and echocardiogram (minimum 3 months for athletes) 1
Alternative NSAID Options
If ibuprofen is not tolerated, the dosing range can be adjusted to 1200-2400 mg/day total for recurrent cases 1, though the standard 1800 mg/day (600 mg TID) remains first-line for acute presentation 1. Indomethacin (25-50 mg every 8 hours) is an alternative but has higher CNS adverse effects 1, 4.